Augustine Therapeutics
Biotechnology Research • 
Leuven, Flemish Region, Belgium • 21-50 Employees
Company overview
| Headquarters | Gaston Geenslaan 1, Leuven, Flemish Region 3001, BE |
| Website | |
| NAICS | 541714 |
| Founded | 2019 |
| Employees | 21-50 |
| Socials |
Key Contacts at Augustine Therapeutics
Sandrien Janssens
Director Of Cmc And Process Development
Gerhard Koenig
Chief Executive Officer
Joris De Wit
Scientific Co-Founder
Augustine Therapeutics Email Formats
Augustine Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@augustinetx.com), used 68.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@augustinetx.com | 68.4% |
{first name}.{last name} | john.doe@augustinetx.com | 31.6% |
About Augustine Therapeutics
Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 while preserving its beneficial non-catalytic functions. Augustine’s lead program, AGT-100216, is the first selective HDAC6 inhibitor for long-term treatment of Charcot-Marie-Tooth (CMT) disease. With its novel non-hydroxamate, non-hydrazide producing chemotype, Augustine’s HDAC6 approach is selective, avoids the limitations of other chemotypes, and built for chronic diseases. With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.
Augustine Therapeutics revenue & valuation
| Annual revenue | $1,600,000 |
| Revenue per employee | $67,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,200,000 |
| Total funding | $107,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Augustine Therapeutics has 11 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore Augustine Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Augustine Therapeutics Tech Stack
Discover the technologies and tools that power Augustine Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Tag managers
JavaScript libraries
Reverse proxies
Programming languages
JavaScript libraries
JavaScript libraries
Miscellaneous
JavaScript frameworks
Miscellaneous
JavaScript libraries
Spain
Singapore
Norway
Frequently asked questions
4.8
40,000 users
